Karin W. Littink

1.1k citations
13 papers · 711 indexed · h-index 12

Karin W. Littink

13 papers receiving 706 citations

Peers

Karin W. Littink
Comparison fields: 5 of 44
  • Molecular Biology 669
  • Ophthalmology 328
  • Cellular and Molecular Neuroscience 146
  • Genetics 142
  • Cell Biology 117
Replace Marie‐Elise Lancelot with:
Marie‐Elise Lancelot France
Julie E. Smith United States
Seok Hong Min United States
Aline Antonio France
Corinne Leowski France
Sharola Dharmaraj United States
Xufeng Dai China
Karina E Guziewicz United States
Christelle Michiels France
Jeaneen L. Andorf United States
Karin W. Littink relative to Marie‐Elise Lancelot France Marie‐Elise Lancelot's profile →
Citations per field
00.5×1.5×
Marie‐Elise Lancelot · 1×
Citations per year

Countries citing papers authored by Karin W. Littink

Since Specialization
Citations

This map shows the geographic impact of Karin W. Littink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin W. Littink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin W. Littink more than expected).

Fields of papers citing papers by Karin W. Littink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin W. Littink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin W. Littink. The network helps show where Karin W. Littink may publish in the future.

Co-authorship network of co-authors of Karin W. Littink

This figure shows the co-authorship network connecting the top 25 collaborators of Karin W. Littink. A scholar is included among the top collaborators of Karin W. Littink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin W. Littink. Karin W. Littink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 30
2 34
3 2
4 12
5 54
6 68
7 71
8 65
9 56
10 53
11 81
12 59
13 126

About Karin W. Littink

Karin W. Littink is a scholar working on Ophthalmology, Cell Biology and Molecular Biology, having authored 13 papers that have together received 711 indexed citations. Recurring topics across this work include Retinal Development and Disorders (12 papers), Retinal Diseases and Treatments (8 papers) and Ocular Disorders and Treatments (3 papers). The work is most often cited by research in Ophthalmology (328 citations), Molecular Biology (669 citations) and Cellular and Molecular Neuroscience (146 citations). Karin W. Littink has collaborated with scholars based in Netherlands, Germany and Canada. Frequent co-authors include Frans P.M. Cremers, Rob W.J. Collin, Anneke I. den Hollander, L. Ingeborgh van den Born, Carel B. Hoyng, Marijke N. Zonneveld, B. Jeroen Klevering, Robert K. Koenekoop, Ellen A.W. Blokland and Tim M. Strom. Their work appears in journals such as Ophthalmology, The American Journal of Human Genetics and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026